selected publications
- Actomyosin-mediated cellular tension promotes Yap nuclear translocation and myocardial proliferation through α5 integrin signaling. Development (Cambridge, England). 2023 Academic Article GET IT
- Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia & lymphoma. 2022 Academic Article GET IT
-
Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression.
Clinical science (London, England : 1979).
2022
Review
GET IT
Times cited: 5 -
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response.
Blood advances.
2020
Academic Article
GET IT
Times cited: 4 -
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy.
Leukemia & lymphoma.
2020
Letter
GET IT
Times cited: 1 -
Systemic Delivery of Anti-Integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn Wounds.
Advances in wound care.
2020
Academic Article
GET IT
Times cited: 10 - Right- versus Left-Sided Chest Ports in Oncologic Patients with a History of Right-Sided Port Removal: Are There Any Differences in the Complication Rates?. Journal of vascular and interventional radiology : JVIR. 2019 Academic Article GET IT
-
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 3 -
Somatic mutations precede acute myeloid leukemia years before diagnosis.
Nature medicine.
2018
Academic Article
GET IT
Times cited: 338 -
Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.
Blood.
2018
Letter
GET IT
Times cited: 13 -
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology.
2015
Review
GET IT
Times cited: 66 -
Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 55 -
Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome.
Leukemia research.
2010
Academic Article
GET IT
Times cited: 8 -
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Cancer.
2008
Academic Article
GET IT
Times cited: 45 -
Vitreoretinal complications of retinoblastoma treatment.
Retina (Philadelphia, Pa.).
2006
Academic Article
GET IT
Times cited: 22